Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This appears to be a minor software version update with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-02-13T18:14:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:30.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears on the page, replacing v3.4.0; there are no visible changes to trial content or details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:20:31.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Show glossary option added to the page interface. Minor text updates include capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' and the revision version updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T06:22:52.000Z thumbnail image
  6. Check
    34 days ago
    Change Detected
    Summary
    The update timestamp label changes from 'Last Update Posted (Estimated)' to 'Last Update Posted' on the Study Details page.
    Difference
    0.0%
    Check dated 2026-01-22T05:01:02.000Z thumbnail image
  7. Check
    41 days ago
    Change Detected
    Summary
    Added a page revision note: 'Revision: v3.3.4' and removed 'Revision: v3.3.3' (metadata only; no impact on study details). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:55:50.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.